ENDOSCOPIC SLEEVE GASTROPLASTY

No surgery is performed, The stomach is reduced by 60 - 70% so that the patient loses weight.
Type of anesthesia - General
Hospitalization - Ambulatory, no hospitalization required
Time of incapacity - 5 days

DR. NÚÑEZ SANTANA - ENDOSCOPIC SLEEVE GASTRIC

WHAT IS ENDOSCOPIC SLEEVE GASTROPLASTY (ESG)?

ESG is a minimal invasive procedure performed endoscopically by a gastroenterologist or surgeon that uses a small suturing device and camera to reduce the size of the stomach from the inside.

DR. NÚÑEZ SANTANA - ENDOSCOPIC SLEEVE GASTRIC

HOW IS ESG DIFFERENT THAN TRADITIONAL BARIATRIC SURGERY?

ESG is performed endoscopically, meaning there are no incisions or scars, and most patients can go home the same day.

You can start your weight loss journey today.

Our appointment specialists are ready to help you find the best weight loss surgery for you.
DR. NÚÑEZ SANTANA - ENDOSCOPIC SLEEVE GASTRIC

HOW MUCH WEIGHT DO PATIENTS LOSE?

In a randomized trial, patients undergoing ESG lost 13% of their total body weight at 1 year, and the majority of weight loss was maintained out to 2 years.’

DR. NÚÑEZ SANTANA - ENDOSCOPIC SLEEVE GASTRIC

WHAT ARE THE POTENTIAL POSITIVE HEALTH IMPACTS OF ESG?

In a US randomized trial, 61.1% of patients with Type 2 Diabetes lost at least 10% TBWL” and 70.0% showed improvement in their diabetes, as determined by their doctor.?
In that same study, 59.5% of patients with hypertension lost at least 10% TBWL” and 64.3% showed improvement in their hypertension, as determined by their doctor?

DR. NÚÑEZ SANTANA - ENDOSCOPIC SLEEVE GASTRIC

HOW MANY ESG PROCEDURE
HAVE BEEN DONE?

Over 250 publications and abstracts have reported outcomes in >10,000 patients receiving ESG worldwide.  In the US.

DR. NÚÑEZ SANTANA - ENDOSCOPIC SLEEVE GASTRIC

WHO IS A CANDIDATE FOR ESG?

Apollo ESG™ is indicated for adult patients with obesity with Body Mass Index (BMI) between 30-50 kg/m2 who have not been able to lose weight or maintain weight loss through more conservative measures.

 

You can start your weight loss journey today.

Our appointment specialists are ready to help you find the best weight loss surgery for you.
DR. NÚÑEZ SANTANA - ENDOSCOPIC SLEEVE GASTRIC

WHICH TYPE OF PERSONS
SHOULD NOT HAVE ESG?

Some contraindications to Apollo ESG™M include inability to have an endoscopic procedure, malignant tissue, large hiatal hernia, potential bleeding gastric lesions, eating disorders, women who are pregnant, and patients using certain types of blood thinning medications.

DR. NÚÑEZ SANTANA - ENDOSCOPIC SLEEVE GASTRIC

WHAT ARE THE MOST COMMON SIDE EFFECTS?

Some of the common side effects are gastrointestinal symptoms such as nausea, abdominal pain, vomiting, constipation, burping, heartburn or diarrhea, which typically resolve within 30-60 days.

DR. NÚÑEZ SANTANA - ENDOSCOPIC SLEEVE GASTRIC

IS THE PROCEDURE PERMANENT?

Over time, there will be scarring and bridging tissue to maintain the reduced stomach size and sleeve-like shape. However, the procedure can be reversed by endoscopically cutting these bridges and removing sutures.
In the event the sutures loosen and the sleeve-like shape stretches, retightening can be performed.